Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 35,805 | 33,485 | 21,438 | 17,993 | 11,589 |
| Operating Income | -35,805 | -33,485 | -21,438 | -17,993 | -11,589 |
| Interest Expense | 578 | 604 | 667 | 0 | 0 |
| Other Income | 836 | 755 | 369 | -263 | 16 |
| Pre-tax Income | -35,546 | -33,334 | -21,736 | -18,256 | -11,573 |
| Net Income Continuous | -35,546 | -33,334 | -21,736 | -18,256 | -11,573 |
| Net Income | $-35,546 | $-33,334 | $-21,736 | $-18,256 | $-11,573 |
| EPS Basic Total Ops | -0.64 | -0.61 | -0.43 | 0.20 | -1.37 |
| EPS Basic Continuous Ops | -0.63 | -0.61 | -0.43 | 0.21 | -1.37 |
| EPS Diluted Total Ops | -0.64 | -0.61 | -0.43 | 0.20 | -1.37 |
| EPS Diluted Continuous Ops | -0.63 | -0.61 | -0.43 | 0.21 | -1.37 |
| EBITDA(a) | $-35,805 | $-33,485 | $-21,438 | $-17,993 | $-11,589 |